Sponsor Check › Person
Related person on Form D filings · address states as listed: CA, MA · listed Jun 30, 2009 → Jun 20, 2018
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:56 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
No SEC search has run yet for this person.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
1 of 46 offerings reports sales commissions totalling $1,950,000; 1 reports finder's fees totalling $1,098,482; 2 report proceeds to related persons totalling $2,000,000. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Aug 5, 2020 D File 021-372585 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 20, 2018 D File 021-314950 | $0 (est.) | $0 (est.) | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 20, 2018 D File 021-314951 | $0 (est.) | $0 (est.) | $0 (est.) | None listed on this filing |
| EDGAR ↗ | May 30, 2018 D File 021-313514 | $1,950,000 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 31, 2017 D File 021-297749 | $0 | $1,098,482 (est.) | $0 | None listed on this filing |
| EDGAR ↗ | Aug 14, 2017 D File 021-292750 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 2, 2017 D/A File 021-275680 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 10, 2017 D File 021-280503 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 27, 2016 D File 021-264004 | $0 | $0 | $0 The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof). | None listed on this filing |
| EDGAR ↗ | Oct 30, 2015 D File 021-250445 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 30, 2015 D File 021-242824 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 30, 2015 D File 021-242825 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 30, 2015 D File 021-242830 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 30, 2015 D File 021-242834 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 30, 2015 D File 021-242833 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 30, 2015 D File 021-242832 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 17, 2015 D File 021-234129 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 24, 2014 D File 021-230841 | $0 | $0 | $1,300,000 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 17, 2014 D File 021-219307 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 17, 2014 D File 021-219340 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 26, 2014 D File 021-212557 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 26, 2014 D File 021-212558 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 14, 2014 D/A File 021-192644 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 14, 2014 D File 021-211989 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 11, 2014 D/A File 021-183127 | $0 | $0 | $700,000 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 4, 2013 D File 021-207407 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 16, 2013 D File 021-204687 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 22, 2013 D File 021-193796 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 22, 2013 D/A File 021-164604 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 2, 2013 D/A File 021-170050 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 11, 2012 D/A File 021-182532 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 9, 2012 D File 021-186732 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 8, 2012 D/A File 021-166458 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 29, 2012 D File 021-180572 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 10, 2012 D File 021-173278 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 8, 2011 D/A File 021-147705 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 15, 2011 D File 021-162993 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 15, 2011 D File 021-162994 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 2, 2011 D/A File 021-127107 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 22, 2010 D File 021-152404 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 30, 2010 D/A File 021-141429 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 19, 2010 D File 021-140790 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 7, 2010 D File 021-125813 | $0 | $0 | $0 (est.) Working capital | None listed on this filing |
| EDGAR ↗ | Feb 25, 2010 D/A File 021-136977 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 11, 2009 D/A File 021-128190 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 2, 2009 D File 021-66780 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Albamunity, Inc. | Executive Officer, Director | Aug 5, 2020 | D | $20,000,000 similar: $1,694,259–$16,000,000 | $5,000,000 | 6 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | HALIO, INC. | Director | Jun 20, 2018 | D | $54,620,450 similar: $1,100,015–$10,001,163 | $23,585,313 | 19 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | HALIO, INC. | Director | Jun 20, 2018 | D | $82,602,983 similar: $1,100,015–$10,001,163 | $82,602,983 | 16 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Cidara Therapeutics, Inc. group: Trius | Director | May 30, 2018 | D | $1,874,999 similar: $2,000,000–$19,999,994 | $1,562,499 | 16 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Cidara Therapeutics, Inc. group: Trius | Director | Oct 31, 2017 | D | $20,160,000 similar: $2,000,000–$19,999,994 | $20,160,000 | 16 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | RENNOVIA INC | Director | Aug 14, 2017 | D | $3,000,000 similar: $1,100,015–$10,001,163 | $2,000,000 | 4 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Expansion Therapeutics, Inc. | Executive Officer, Director | Jun 2, 2017 | D/A | $5,000,000 similar: $1,694,259–$16,000,000 | $5,000,000 | 3 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | RENNOVIA INC | Director | Feb 10, 2017 | D | $6,000,000 similar: $1,100,015–$10,001,163 | $3,000,000 | 5 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Expansion Therapeutics, Inc. | Executive Officer, Director | Dec 6, 2016 | D | $4,000,000 similar: $1,694,259–$16,000,000 | $250,000 | 2 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | 5AM Ventures V, L.P. | Director Managing Member of the General Partner of the Issuer | May 27, 2016 | D | $285,000,000 similar: $155,000–$5,250,000 | $285,000,000 | 80 similar: 4–27 | $25,000 similar: $1,000–$100,000 |
| EDGAR ↗ | HALIO, INC. | Director | Oct 30, 2015 | D | $33,073,962 similar: $500,000–$7,000,000 | $29,573,963 | 8 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Pulmatrix, Inc. group: Pulmatrix | Director | Jun 30, 2015 | D | $45,468,112 similar: $1,694,259–$16,000,000 | $21,383,416 | 12 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Pulmatrix, Inc. group: Pulmatrix | Director | Jun 30, 2015 | D | $935,000 similar: $1,694,259–$16,000,000 | $935,000 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Pulmatrix, Inc. group: Pulmatrix | Director | Jun 30, 2015 | D | $687,500 similar: $1,694,259–$16,000,000 | $687,500 | 3 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Pulmatrix, Inc. group: Pulmatrix | Director | Jun 30, 2015 | D | $210,003 similar: $1,694,259–$16,000,000 | $0 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Pulmatrix Operating Company, Inc. group: Pulmatrix | Director | Jun 30, 2015 | D | $1,621,422 similar: $1,694,259–$16,000,000 | $1,621,422 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Pulmatrix Operating Company, Inc. group: Pulmatrix | Director | Jun 30, 2015 | D | $34,124,543 similar: $1,694,259–$16,000,000 | $10,000,000 | 11 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Cidara Therapeutics, Inc. group: Trius | Director | Feb 17, 2015 | D | $42,019,999 similar: $2,000,000–$19,999,994 | $42,019,999 | 19 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Novira Therapeutics, Inc. | Director | Dec 24, 2014 | D | $9,000,000 similar: $1,694,259–$16,000,000 | $9,000,000 | 10 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Cidara Therapeutics, Inc. group: Trius | Director | Jun 17, 2014 | D | $42,743,763 similar: $2,000,000–$19,999,994 | $30,332,199 | 8 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Cidara Therapeutics, Inc. group: Trius | Director | Jun 17, 2014 | D | $6,000,472 similar: $2,000,000–$19,999,994 | $6,000,472 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | HALIO, INC. | Director | Feb 26, 2014 | D | $4,000,000 similar: $1,000,000–$10,000,000 | $4,000,000 | 4 similar: 1–11 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | HALIO, INC. | Director | Feb 26, 2014 | D | $7,085,039 similar: $1,000,000–$10,000,000 | $7,085,039 | 4 similar: 1–11 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | RENNOVIA INC | Director | Feb 14, 2014 | D/A | $8,000,000 similar: $1,100,015–$10,001,163 | $8,000,000 | 4 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | RENNOVIA INC | Director | Feb 14, 2014 | D | $33,320,656 similar: $1,100,015–$10,001,163 | $23,320,658 | 5 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Novira Therapeutics, Inc. | Director | Feb 11, 2014 | D/A | $29,800,000 similar: $1,694,259–$16,000,000 | $27,995,233 | 10 similar: 1–13 | $58,230 similar: $10,000–$55,000 |
| EDGAR ↗ | RENNOVIA INC | Director | Dec 9, 2013 | D/A | $7,000,000 similar: $1,100,015–$10,001,163 | $7,000,000 | 4 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | 5AM Co-Investors IV, L.P. | Executive Officer | Dec 4, 2013 | D | $10,000,000 similar: $155,000–$5,250,000 | $10,000,000 | 32 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | 5AM Ventures IV, L.P. | Executive Officer | Oct 16, 2013 | D | $240,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | RENNOVIA INC | Director | Aug 28, 2013 | D/A | $5,000,000 | $5,000,000 | 4 | No minimum reported |
| EDGAR ↗ | RENNOVIA INC | Director | Apr 10, 2013 | D/A | $2,000,000 | $2,000,000 | 4 | No minimum reported |
| EDGAR ↗ | Achaogen Inc | Director | Mar 22, 2013 | D | $30,683,703 | $18,905,707 | 15 | No minimum reported |
| EDGAR ↗ | RENNOVIA INC | Director | Mar 1, 2013 | D | $2,000,000 | $1,000,000 | 4 | No minimum reported |
| EDGAR ↗ | Pulmatrix Operating Company, Inc. group: Pulmatrix | Director | Feb 22, 2013 | D/A | $24,000,000 | $20,500,000 | 11 | No minimum reported |
| EDGAR ↗ | RENNOVIA INC | Director | Jan 2, 2013 | D/A | $28,383,533 | $28,383,533 | 4 | No minimum reported |
| EDGAR ↗ | Relypsa Inc | Director | Dec 11, 2012 | D/A | $80,000,200 | $65,000,192 | 15 | No minimum reported |
| EDGAR ↗ | Variation Biotechnologies (US), Inc. | Director | Nov 9, 2012 | D | $1,200,000 | $1,200,000 | 4 | No minimum reported |
| EDGAR ↗ | HALIO, INC. | Director | Nov 8, 2012 | D/A | $16,000,000 | $16,000,000 | 8 | No minimum reported |
| EDGAR ↗ | Pulmatrix Operating Company, Inc. group: Pulmatrix | Director | Oct 26, 2012 | D/A | $17,000,000 | $17,000,000 | 11 | No minimum reported |
| EDGAR ↗ | Relypsa Inc | Director | Oct 5, 2012 | D/A | $80,000,200 | $62,412,304 | 14 | No minimum reported |
| EDGAR ↗ | Novira Therapeutics, Inc. | Director | Aug 23, 2012 | D | $26,495,221 | $10,995,221 | 8 | $58,230 |
| EDGAR ↗ | Relypsa Inc | Director | Aug 10, 2012 | D | $80,000,200 | $49,677,652 | 13 | No minimum reported |
| EDGAR ↗ | Variation Biotechnologies (US), Inc. | Director | Jun 29, 2012 | D | $1,200,000 | $1,200,000 | 4 | No minimum reported |
| EDGAR ↗ | RENNOVIA INC | Director | Jun 5, 2012 | D/A | $28,383,333 | $26,383,333 | 5 | No minimum reported |
| EDGAR ↗ | Variation Biotechnologies (US), Inc. | Director | Feb 10, 2012 | D | $2,200,000 | $2,200,000 | 4 | No minimum reported |
| EDGAR ↗ | RENNOVIA INC | Director | Dec 14, 2011 | D | $23,000,000 | $22,333,333 | 4 | No minimum reported |
| EDGAR ↗ | HALIO, INC. | Director | Sep 27, 2011 | D | $16,000,000 | $9,000,000 | 8 | $37,000 |
| EDGAR ↗ | Pulmatrix Operating Company, Inc. group: Pulmatrix | Director | Aug 17, 2011 | D | $14,000,000 | $5,000,000 | 11 | No minimum reported |
| EDGAR ↗ | Relypsa Inc | Director | Aug 8, 2011 | D/A | $70,129,747 | $70,129,747 | 12 | No minimum reported |
| EDGAR ↗ | Variation Biotechnologies (US), Inc. | Director | Jul 15, 2011 | D | $3,500,000 | $3,500,000 | 4 | No minimum reported |
| EDGAR ↗ | Variation Biotechnologies (US), Inc. | Director | Jul 15, 2011 | D | $4,331,932 | $4,331,932 | 4 | No minimum reported |
| EDGAR ↗ | RENNOVIA INC | Director | May 2, 2011 | D/A | $17,000,000 | $16,333,333 | 4 | No minimum reported |
| EDGAR ↗ | SEMPRUS BIOSCIENCES CORP | Director | Dec 22, 2010 | D | $18,804,034 | $9,004,031 | 5 | No minimum reported |
| EDGAR ↗ | Relypsa Inc | Director | Sep 14, 2010 | D | $70,129,747 | $35,129,747 | 12 | No minimum reported |
| EDGAR ↗ | Relypsa Inc | Director | Jul 30, 2010 | D/A | $6,000,060 | $6,000,060 | 11 | $1,600 |
| EDGAR ↗ | Relypsa Inc | Director | May 3, 2010 | D | $4,000,040 | $4,000,040 | 11 | $3,000 |
| EDGAR ↗ | Achaogen Inc | Director | Apr 19, 2010 | D | $56,413,706 | $35,360,873 | 15 | No minimum reported |
| EDGAR ↗ | WAVERX INC | Director | Apr 7, 2010 | D | $502,512 | $502,512 | 3 | No minimum reported |
| EDGAR ↗ | 5AM Co-Investors III, L.P. | Executive Officer | Feb 25, 2010 | D/A | $5,485,000 | $5,485,000 | 30 | $25,000 |
| EDGAR ↗ | 5AM Co-Investors III, L.P. | Executive Officer | Dec 17, 2009 | D | $2,115,000 | $2,115,000 | 20 | $25,000 |
| EDGAR ↗ | 5AM VENTURES III, L.P. | Executive Officer | Dec 11, 2009 | D/A | $197,825,000 | $197,825,000 | 43 | $25,000 |
| EDGAR ↗ | Pulmatrix Operating Company, Inc. group: Pulmatrix | Director | Nov 2, 2009 | D | $30,294,395 | $15,452,728 | 10 | No minimum reported |
| EDGAR ↗ | RENNOVIA INC | Director | Sep 4, 2009 | D | $12,363,333 | $6,030,000 | 4 | No minimum reported |
| EDGAR ↗ | 5AM VENTURES III, L.P. | Executive Officer | Jul 1, 2009 | D/A | $159,250,000 | $159,250,000 | 34 | $25,000 |
| EDGAR ↗ | RENNOVIA INC | Director | Jun 30, 2009 | D | $2,500,000 | $2,500,000 | 2 | No minimum reported |
| EDGAR ↗ | 5AM VENTURES III, L.P. | Executive Officer | Apr 24, 2009 | D/A | $139,250,000 | $139,250,000 | 31 | $25,000 |
| EDGAR ↗ | 5AM VENTURES III, L.P. | Executive Officer | Mar 19, 2009 | D | $119,250,000 | $119,250,000 | 29 | $25,000 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (6 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
People and management entities the issuers listed as related persons on the same Form D filings as Scott Rocklage. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Scott Rocklage appears on a new Form D, or when a court case or SEC action is matched to them. See plans →